Evidence map›Paper›PMID 31780731›Full record

ArticleScientific reports2019

The protein tyrosine kinase SYK regulates the alternative p38 activation in liver during acute liver inflammation.

Bo-Ram Bang, Kyung Ho Han, Goo-Young Seo, Michael Croft, Young Jun Kang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Syk inhibitor attenuates lupus in FcγRIIbCell death discovery · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Bo-Ram BangDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, 92037, USA.ORCID http://orcid.org/0000-0001-5716-6640
Kyung Ho HanDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA, 92037, USA.ORCID http://orcid.org/0000-0001-6907-1462
Goo-Young SeoDivision of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA.
Michael CroftDivision of Immune Regulation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA.
Young Jun KangDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, 92037, USA. ykang@mmrx.org.
La Jolla Institute for Immunology · USScripps Research Institute · USUniversity of Southern California · US

Funding

Mechanism of 4-1BBL-mediated sustained inflammation: target of anti-inflammationR01AI088229 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI KANG, YOUNG JUN · 2010 to 2014
$2.1M
NIAID NIH HHS R01 AI088229
6 · The paper itself

Abstract

Two distinct p38 signaling pathways, classical and alternative, have been identified to regulate inflammatory responses in host defense and disease development. The role of alternative p38 activation in liver inflammation is elusive, while classical p38 signaling in hepatocytes plays a role in regulating the induction of cell death in autoimmune-mediated acute liver injury. In this study, we found that a mutation of alternative p38 in mice augmented the severity of acute liver inflammation. Moreover, TNF-induced hepatocyte death was augmented by a mutation of alternative p38, suggesting that alternative p38 signaling in hepatocytes contributed more significantly to the pathology of acute liver injury. Furthermore, SYK-Vav-1 signaling regulates alternative p38 activation and the downregulation of cell death in hepatocytes. Therefore, it is suggested that alternative p38 signaling in the liver plays a critical role in the induction and subsequent pathological changes of acute liver injury. Collectively, our results imply that p38 signaling in hepatocytes plays a crucial role to prevent excessive liver injury by regulating the induction of cell death and inflammation.

Indexed as

MAP Kinase Signaling SystemAnimalsCell DeathCells, CulturedCytokinesFemaleHepatitis, AnimalHepatocytesMaleMiceMice, Inbred C57BLMutationp38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-vavSyk KinaseCytokinesp38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-vavSyk KinaseVav1 protein, mouse

Identifiers

PMID31780731
PMCPMC6882802
OpenAlexW2991340022

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.